Healthcare Wearable Robots Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 – 2032

September 2024 | 120 pages | ID: H1A168464783EN
Global Market Insights

US$ 4,365.00 US$ 4,850.00 -10 %
Offer valid until June 30, 2025!

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Global Healthcare Wearable Robots Market, valued at USD 443 million in 2023, is expected to grow at a remarkable CAGR of 29.1% from 2024 to 2032. This growth is largely due to the rising prevalence of disabilities, increased emphasis on patient independence, government support, and interest in exoskeleton technologies. As healthcare costs rise and the demand for advanced rehabilitation solutions grows, healthcare providers are increasingly adopting exoskeletons, which has spurred public and private sector investments in mobility-improving technologies. Wearable robots provide essential support for patients with conditions such as Parkinson’s disease and muscle-related disorders, offering innovative rehabilitation options that enhance mobility and independence. The increased need for long-term care and rehabilitation for such conditions is driving the adoption of these advanced robotic devices in healthcare settings.
These wearable robots are robotic devices that patients can wear to assist with movement and rehabilitation, particularly beneficial for those with mobility impairments. Commonly designed as exoskeletons or robotic suits, they improve physical capabilities and aid those with disabilities or neurodegenerative diseases like Parkinson’s, stroke, or spinal injuries. The market is categorized by product type, with powered devices generating the highest revenue of USD 365.9 million in 2023. Powered devices are crucial for movement assistance, rehabilitation, and helping healthcare professionals with tasks like patient lifting. Additionally, in terms of structure, soft wearable robots, which are flexible and lightweight, have dominated the market due to their comfort and adaptability, especially for patients needing long-term rehabilitation.
Material-wise, the combination segment leads, valued at USD 123 million in 2023. By using a blend of materials, these devices offer lightweight yet durable solutions that balance strength and ease of movement. This customization provides tailored support for varying mobility needs, allowing for specific levels of flexibility and strength. For body parts, the lower body segment holds the largest share, valued at USD 327.4 million. Advances in sensor technology, actuators, and battery life enhance the functionality of these robots, providing real-time movement assistance, particularly valuable for patients with spinal cord injuries.
The application segment shows the most significant share of stroke rehabilitation, with a value of USD 235.3 million in 2023. These robots are critical in promoting early mobility for stroke patients, thus reducing long-term disability risks. Finally, in end-use, homecare is a rapidly growing segment, driven by the demand for home-based rehabilitation. In North America, the market holds substantial revenue, with the U.S. leading due to its high incidence of stroke and neurological disorders. This trend toward home rehabilitation is also motivated by a shift toward outpatient care and reduced healthcare costs, enhancing patient independence and recovery outcomes.
.
Report Content

CHAPTER 1 METHODOLOGY & SCOPE

1.1 Market scope & definitions
1.2 Research design
  1.2.1 Research approach
  1.2.2 Data collection methods
1.3 Base estimates & calculations
  1.3.1 Base year calculation
  1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
  1.5.1 Primary sources
  1.5.2 Data mining sources

CHAPTER 2 EXECUTIVE SUMMARY

2.1 Industry 360° synopsis

CHAPTER 3 INDUSTRY INSIGHTS

3.1 Industry ecosystem analysis
3.2 Industry impact forces
  3.2.1 Growth drivers
    3.2.1.1 Growing cases of Parkinson’s and other muscle-related diseases
    3.2.1.2 Increasing investment in the development of exoskeleton technology
    3.2.1.3 Technological advancements in wearable robots
  3.2.2 Industry pitfalls & challenges
    3.2.2.1 High cost of equipment
3.3 Growth potential analysis
3.4 Regulatory landscape
  3.4.1 North America
  3.4.2 Europe
  3.4.3 Asia Pacific
  3.4.4 Latin America
  3.4.5 MEA
3.5 Technology & innovation landscape
  3.5.1 Thought control in exoskeleton
  3.5.2 4D material for exosuits
  3.5.3 Structured functional textiles based multi-joint-soft-exosuit
3.6 Pricing analysis
3.7 Reimbursement scenario
3.8 Porter's analysis
3.9 PESTEL analysis
3.10 Future market trends
3.11 Gap analysis

CHAPTER 4 COMPETITIVE LANDSCAPE, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

CHAPTER 5 MARKET ESTIMATES AND FORECAST, BY PRODUCT TYPE, 2021 – 2032 ($ MN)

5.1 Key trends
5.2 Powered devices
  5.2.1 Hybrid
  5.2.2 Electric actuator
  5.2.3 Pneumatic actuator
  5.2.4 Hydraulic actuator
  5.2.5 Other powered devices
5.3 Passive devices

CHAPTER 6 MARKET ESTIMATES AND FORECAST, BY STRUCTURE, 2021 – 2032 ($ MN)

6.1 Key trends
6.2 Soft
6.3 Rigid

CHAPTER 7 MARKET ESTIMATES AND FORECAST, BY MATERIAL, 2021 – 2032 ($ MN)

7.1 Key trends
7.2 Combination
7.3 3D printed
7.4 Metal
7.5 Plastic
7.6 Other materials

CHAPTER 8 MARKET ESTIMATES AND FORECAST, BY BODY PART, 2021 – 2032 ($ MN)

8.1 Key trends
8.2 Lower body
8.3 Upper body
8.4 Full body

CHAPTER 9 MARKET ESTIMATES AND FORECAST, BY APPLICATION, 2021 – 2032 ($ MN)

9.1 Key trends
9.2 Stroke
9.3 Spinal cord injury
9.4 Traumatic brain injury
9.5 Other applications

CHAPTER 10 MARKET ESTIMATES AND FORECAST, BY END-USE, 2021 – 2032 ($ MN)

10.1 Key trends
10.2 Institutional
10.3 Homecare

CHAPTER 11 MARKET ESTIMATES AND FORECAST, BY REGION, 2021 – 2032 ($ MN)

11.1 Key trends
11.2 North America
  11.2.1 U.S.
  11.2.2 Canada
11.3 Europe
  11.3.1 Germany
  11.3.2 UK
  11.3.3 France
  11.3.4 Spain
  11.3.5 Italy
  11.3.6 Netherlands
  11.3.7 Rest of Europe
11.4 Asia Pacific
  11.4.1 China
  11.4.2 Japan
  11.4.3 India
  11.4.4 Australia
  11.4.5 South Korea
  11.4.6 Rest of Asia Pacific
11.5 Latin America
  11.5.1 Brazil
  11.5.2 Mexico
  11.5.3 Argentina
  11.5.4 Rest of Latin America
11.6 Middle East and Africa
  11.6.1 South Africa
  11.6.2 Saudi Arabia
  11.6.3 UAE
  11.6.4 Rest of Middle East and Africa

CHAPTER 12 COMPANY PROFILES

12.1 ANGEL ROBOTICS
12.2 Bioservo Technologies AB
12.3 CYBERDYNE INC.
12.4 DIH Medical
12.5 ExoAtlet
12.6 Ekso Bionics Holdings Inc.
12.7 Fourier Intelligence
12.8 GenElek Technologies Pvt. Ltd.
12.9 Myomo, Inc.
12.10 Ottobock SE & Co. KGaA
12.11 ReWalk Robotics
12.12 Reha-Stim Medtec AG
12.13 Rex Bionics Ltd.
12.14 Wearable Robotics srl
12.15 TYROMOTION GMBH


More Publications